[Therapeutic and preventive effects of Craviten in myocardial lesions caused by carbon monoxide poisoning].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced* / Q000517:prevention & control; D002249:Carbon Monoxide Poisoning / Q000150:complications*; D002986:Clinical Trials as Topic; D005029:Ethylenediamines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos
D000889:Anti-Arrhythmia Agents; D005029:Ethylenediamines; D010919:Placebos; C030706:butobendin
Badania nad działaniem leczniczym i zapobiegawczym Cravitenu w uszkodzeniach mieśnia serca obserwowanych w przebiegu zatruć tlenkiem wegla.